Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Sep 5;25(1):145.
doi: 10.1186/s10194-024-01851-x.

Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension

Affiliations
Observational Study

Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension

Sina Zaic et al. J Headache Pain. .

Abstract

Background: Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by increased intracranial pressure. Whilst lumbar puncture (LP) is necessary for the diagnosis of IIH, its therapeutic effect remains unclear. Our aim was to evaluate the therapeutic effect of a single LP in people with IIH (pwIIH).

Methods: In this prospective observational study, we analysed short-term neurological and ophthalmological outcomes in pwIIH before, one (D1) and seven days (D7) after the LP. The primary outcome was the change in papilledema degree from baseline. Secondary outcomes included visual outcomes, morphological changes in optical coherence tomography (peripapillary retinal nerve fibre layer [pRNFL] thickness and ganglion cell layer [GCL] volume) and transbulbar sonography (arachnoid optic nerve sheath diameter [AONSD]), and headache outcomes (peak and median headache severity and burden related to headache).

Results: We included 30 pwIIH (mean age 32.8 years [SD 8.4], 93.3% female, median cerebrospinal fluid [CSF] opening pressure 33.0 cmCSF [IQR 26.9-35.3], median body mass index (BMI) 34.8 kg/m2 [IQR 30.9-40.9]). The median papilledema grading at baseline was 2 (Friedman DI (1999) Pseudotumor cerebri. Neurosurg Clin N Am 10(4):609-621 viii); (Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ (2019) The expanding burden of idiopathic intracranial hypertension. Eye Lond Engl 33(3):478-485); (Ab D, Gt L, Nj V, Sl G, Ml M, Nj N et al. (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol [Internet]. Apr [cited 2024 Jun 2];143(4). https://pubmed.ncbi.nlm.nih.gov/17386271/ ) and was significantly reduced at D7 (2 [1-2], p = 0.011). Median pRNFL thickness had decreased significantly at D7 (-9 μm [-62.5, -1.3], p = 0.035), with pRNFL thickness at baseline being associated with the pRNFL change (F(1,11) = 18.79, p = 0.001). Mean AONSD had decreased significantly at both D1 (-0.74 mm [0.14], p < 0.001) and D7 (-0.65 mm [0.17], p = 0.01), with AONSD at baseline being associated with the change in AONSD at both time points (D1: β= -0.89, 95% CI -1.37, -0.42, p = 0.002; D7: β= -0.85, 95% CI -1.42, -0.28, p = 0.007). Peak headache severity was slightly lower at D7 (-1/10 [-3, 0], p = 0.026), whereas median headache severity and headache burden remained unchanged.

Conclusions: This short-term follow-up study in pwIIH undergoing a single LP suggests a moderate effect on ophthalmological but not headache outcomes. The usefulness of LP as a therapeutic measure in IIH remains controversial and should likely be reserved for patients with limited treatment options, e.g., in pregnancy or intolerability to medication.

Keywords: Headache; Idiopathic intracranial hypertension; Lumbar puncture; Visual outcome.

PubMed Disclaimer

Conflict of interest statement

Sina Zaic: declares no conflict of interest relevant to this study.

Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from Alexion, BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Stefan Macher: declares no conflict of interest relevant to this study.

Martin Michl: declares no conflict of interest relevant to this study.

Nina Müller: declares no conflict of interest relevant to this study.

Christoph Mitsch: declares no conflict of interest relevant to this study.

Wolfgang Marik: declares no conflict of interest relevant to this study.

Klaus Novak: declares no conflict of interest relevant to this study.

Christian Wöber: has received honoraria consultancy/speaking from Apomedica, Curelator.

Berthold Pemp: declares no conflict of interest relevant to this study.

Gabriel Bsteh: has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, Celgene/BMS, Lilly, Merck, Novartis, Roche, Sanofi-Genzyme and Teva, and received honoraria for consulting Biogen, Celgene/BMS, Novartis, Roche, Sanofi-Genzyme and Teva. He has received unrestricted research grants from Celgene/BMS and Novartis.

Figures

Fig. 1
Fig. 1
Flowchart of the inclusion/exclusion process. IIH: idiopathic intracranial hypertension, ONSF: optic nerve sheath fenestration
Fig. 2
Fig. 2
Ophthalmological (a) and neurological (b) outcomes in pwIIH before and after lumbar puncture (LP). Neurological outcomes were assessed as the change in their presence from D0 to D7 compared to the month before LP. AONSD: arachnoid optic nerve sheath diameter, GCL: ganglion cell layer, pRNFL: peripapillary retinal nerve fiber layer, D0: before LP, D1: one day after LP, D7: seven days after LP *p < 0.05, **p < 0.01, ***p < 0.001

References

    1. Friedman DI (1999) Pseudotumor Cerebri. Neurosurg Clin N Am 10(4):609–621 viii 10.1016/S1042-3680(18)30161-X - DOI - PubMed
    1. Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ (2019) The expanding burden of idiopathic intracranial hypertension. Eye Lond Engl 33(3):478–485 - PMC - PubMed
    1. Ab D, Gt L, Nj V, Sl G, Ml M, Nj N et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol [Internet]. Apr [cited 2024 Jun 2];143(4). https://pubmed.ncbi.nlm.nih.gov/17386271/ - PubMed
    1. Burkett JG, Ailani J (2018) An up to date review of Pseudotumor Cerebri Syndrome. Curr Neurol Neurosci Rep 18(6):33 10.1007/s11910-018-0839-1 - DOI - PubMed
    1. Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159–1165 10.1212/WNL.0b013e3182a55f17 - DOI - PubMed

Publication types

LinkOut - more resources